Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasia

Suhail Al-Saleh, Andreea Dragulescu, David Manson, Fraser Golding, Jeffrey Traubici, Meir Mei-Zahav, Ian B. MacLusky, Marie E. Faughnan, Susan Carpenter, Felix Ratjen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Objective: To evaluate the utility of transthoracic contrast echocardiography (TTCE) as a screening tool for pulmonary arteriovenous malformations (PAVMs) in children with hereditary hemorrhagic telangiectasia (HHT). Study design: This was a single-center study of children who underwent baseline screening for PAVMs using both TTCE and chest computed tomography (CT) for evaluation of HHT. The CT and TTCE results were prospectively reviewed independently by 2 radiologists and 2 cardiologists blinded to the study results. Results: Both intraobserver and interobserver agreement for interpreting TTCE results were excellent (κ = 0.97 and 0.92, respectively) and higher than the interobserver agreement for CT interpretation (κ = 0.75). The sensitivity and specificity of TTCE to predict PAVMs were 1 and 0.82, respectively, and the positive predictive and negative predictive values were 0.39 and 1, respectively. Conclusion: TTCE is a sensitive test for PAVMs in children with suspected HHT and can be a useful initial screening tool in pediatric HHT.

Original languageEnglish
Pages (from-to)1039-1043.e1
JournalJournal of Pediatrics
Volume160
Issue number6
DOIs
StatePublished - Jun 2012
Externally publishedYes

Keywords

  • AVM
  • Arteriovenous malformation
  • CT
  • Computed tomography
  • HHT
  • Hereditary hemorrhagic telangiectasia
  • NPV
  • Negative predictive value
  • PAVM
  • PPV
  • Positive predictive value
  • Pulmonary arteriovenous malformation
  • TTCE
  • Transthoracic contrast echocardiography

Fingerprint

Dive into the research topics of 'Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasia'. Together they form a unique fingerprint.

Cite this